Cargando…

Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes

BACKGROUND: The identification of circulating biomarkers associated with the risk of type 2 diabetes (T2D) is useful for improving the current prevention strategies in the most at-risk patients. Here, we aimed to investigate the association of plasma apolipoprotein concentrations in prediabetes subj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Croyal, Mikaël, Wargny, Matthieu, Chemello, Kevin, Chevalier, Chloé, Blanchard, Valentin, Bigot-Corbel, Edith, Lambert, Gilles, Le May, Cédric, Hadjadj, Samy, Cariou, Bertrand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822824/ https://www.ncbi.nlm.nih.gov/pubmed/35130909 http://dx.doi.org/10.1186/s12933-022-01452-5

Ejemplares similares

Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: The IT-DIAB study
por: Wargny, Matthieu, et al.
Publicado: (2019)

Effect of Parathyroidectomy on Metabolic Homeostasis in Primary Hyperparathyroidism
por: Frey, Samuel, et al.
Publicado: (2022)

Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort
por: Wargny, Matthieu, et al.
Publicado: (2022)

Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399–1407
por: Cariou, Bertrand, et al.
Publicado: (2020)

Diabète et COVID-19 : les leçons de CORONADO
por: Cariou, Bertrand, et al.
Publicado: (2021)

Reduced Lipoprotein(a) Associated With the Apolipoprotein E2 Genotype Confers Cardiovascular Protection in Familial Hypercholesterolemia
por: Blanchard, Valentin, et al.
Publicado: (2019)

COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO Study
por: Smati, Sarra, et al.
Publicado: (2022)

Glucose-lowering treatments and COVID-19 mortality in T2DM
por: Hadjadj, Samy, et al.
Publicado: (2021)

Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity
por: Bobin-Dubigeon, Christine, et al.
Publicado: (2022)

Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study
por: Cariou, Bertrand, et al.
Publicado: (2021)

Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study
por: Cariou, Bertrand, et al.
Publicado: (2021)

Effect of Omega-3 Fatty Acid Supplementation on the Postprandial Metabolism of Apolipoprotein(a) in Familial Hypercholesterolemia
por: Ying, Qidi, et al.
Publicado: (2023)

Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study
por: Wargny, Matthieu, et al.
Publicado: (2020)

Associations of microvascular complications with all‐cause death in patients with diabetes and COVID‐19: The CORONADO, ABCD COVID‐19 UK national audit and AMERICADO study groups
por: Hadjadj, Samy, et al.
Publicado: (2022)

The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19)
por: Llauradó, Gemma, et al.
Publicado: (2022)

Parathyroidectomy for primary hyperparathyroidism: effect on quality of life after 3 years – a prospective cohort study
por: Frey, Samuel, et al.
Publicado: (2023)

La metformine est associée à une moindre mortalité chez les patients diabétiques hospitalisés pour la COVID-19
por: Lalau, Jean-Daniel, et al.
Publicado: (2021)

Lipoprotein(a) Cellular Uptake Ex Vivo and Hepatic Capture In Vivo Is Insensitive to PCSK9 Inhibition With Alirocumab
por: Chemello, Kévin, et al.
Publicado: (2020)

Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation
por: Hermouet, Sylvie, et al.
Publicado: (2015)

Determination of the target of monoclonal immunoglobulins: a novel diagnostic tool for individualized MGUS therapy, and prevention and therapy of smoldering and multiple myeloma
por: Hermouet, Sylvie, et al.
Publicado: (2023)

PCSK9 is not secreted from mature differentiated intestinal cells
por: Moreau, François, et al.
Publicado: (2021)

Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ(1)-HDL, α-HDL, and triglyceride-rich lipoproteins
por: Chétiveaux, Maud, et al.
Publicado: (2020)

Euglycaemic ketoacidosis during gestational diabetes with concomitant COVID-19 infection
por: Smati, Sarra, et al.
Publicado: (2021)

Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study
por: Harris, Sophie, et al.
Publicado: (2022)

Early recognition of cardiac surgery-associated acute kidney injury: lack of added value of TIMP2 IGFBP7 over short-term changes in creatinine (an observational pilot study)
por: Lakhal, Karim, et al.
Publicado: (2021)

Phenotypic Characteristics and Development of a Hospitalization Prediction Risk Score for Outpatients with Diabetes and COVID-19: The DIABCOVID Study
por: Lasbleiz, Adèle, et al.
Publicado: (2020)

TOTUM‐63, a plant‐based polyphenol‐rich extract, improves glycaemic control in subjects with prediabetes or early stage newly‐diagnosed type 2 diabetes in a randomized, double‐blind, placebo‐controlled trial
por: Sirvent, Pascal, et al.
Publicado: (2022)

Early Insulin Secretory Dysfunction in Korean Prediabetic Subjects: Should We Change the Criteria for "Prediabetes?"
por: Kim, Chul-Hee
Publicado: (2010)

Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia
por: Si-Tayeb, Karim, et al.
Publicado: (2016)

Recurrent coronary syndromes in a patient with isolated very-high lipoprotein (a) and the prothrombin genetic variant rs1799963 (G20210A): a case report
por: Khantalin, Ilya, et al.
Publicado: (2019)

Serum Prolactin and Cardiac Remodeling in Subjects with Prediabetes
por: Kim, Jin Hwa
Publicado: (2017)

PCSK9 and the nervous system: a no-brainer?
por: Jaafar, Ali K., et al.
Publicado: (2023)

Relationship between obesity and severe COVID‐19 outcomes in patients with type 2 diabetes: Results from the CORONADO study
por: Smati, Sarra, et al.
Publicado: (2020)

Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative
por: Cariou, Bertrand, et al.
Publicado: (2022)

LDL lowering effect of PCSK9 inhibition is reduced in women
por: Myasoedova, Veronika A, et al.
Publicado: (2023)

Lipocalin-2 counteracts metabolic dysregulation in obesity and diabetes
por: Mosialou, Ioanna, et al.
Publicado: (2020)

Diabetic Renal Disease
por: Fava, Stephen, et al.
Publicado: (2014)

Apolipoprotein E genotypes of normal and hyperlipidemic subjects.
por: Kim, Y. S., et al.
Publicado: (1993)

Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
por: Lalau, Jean-Daniel, et al.
Publicado: (2021)

Lipoprotein metabolism in familial hypercholesterolemia
por: Chemello, Kévin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fv1o809lbqkd7mld7k5n8kn9ug